Provenienza dei contatti di primo grado di Taka Koda
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Immunis, Inc.
 Immunis, Inc. Miscellaneous Commercial ServicesCommercial Services Immunis, Inc. is a biotechnology company that focuses on developing innovative STEM treatments for immune decline related to age and disease, such as osteoporosis, osteoarthritis, and sarcopenia. The company is based in Irvine, CA. The company is currently conducting clinical trials for participants with leg muscle atrophy or weakness due to osteoarthritis/sarcopenia. Immunis aims to change the course of immune-related diseases and aging.
2
| Holding Company | Miscellaneous Commercial Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Taka Koda tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Pharmaceuticals: Other | Director/Board Member | |
AiVita Biomedical, Inc.
 AiVita Biomedical, Inc. Pharmaceuticals: MajorHealth Technology AiVita Biomedical, Inc. operates as a therapeutic development company which focuses on regenerative and curative medicines. Its products include Provoque facial serum and Provoque eye complex. The company was founded by Hans S. Keirstead in 2016 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Founder | |
| SFC CO LTD | Containers/Packaging | Director/Board Member | |
| University of British Columbia | College/University | Doctorate Degree | |
| University of Cambridge | College/University | Undergraduate Degree | |
Pattern Pharma, Inc.
 Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 3 |
| Corea del Sud | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 4 |
| Chairman | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Hans S. Keirstead | 7 |
| Joelle Hafen | 1 |
- Borsa valori
- Insiders
- Taka Koda
- Connessioni Società
